Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ELV
stocks logo

ELV

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
48.26B
+11.65%
9.279
-8.31%
48.68B
+8.86%
8.690
+3.82%
48.99B
+8.9%
4.458
+16.09%
Estimates Revision
The market is revising Upward the revenue expectations for Elevance Health, Inc. (ELV) for FY2025, with the revenue forecasts being adjusted by 1.22% over the past three months. During the same period, the stock price has changed by -12.68%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.22%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.05%
In Past 3 Month
Stock Price
Go Down
down Image
-12.68%
In Past 3 Month
15 Analyst Rating
up Image0
Wall Street analysts forecast ELV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELV is 494.20 USD with a low forecast of 428.00 USD and a high forecast of 585.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Buy
3 Hold
0 Sell
Strong Buy
up Image0
Current: 375.910
sliders
Low
428.00
Averages
494.20
High
585.00
up Image0
Current: 375.910
sliders
Low
428.00
Averages
494.20
High
585.00
Truist
David MacDonald
Buy
downgrade
$510 -> $500
2025-06-09
Reason
Truist
David MacDonald
Price Target
$510 -> $500
2025-06-09
downgrade
Buy
Reason
Truist analyst David MacDonald lowered the firm's price target on Elevance Health to $500 from $510 and keeps a Buy rating on the shares. The firm is updating its model to reflect the company's recent commentary, though it remains positive on its scale and local market share while also noting its strong growth opportunity across several business lines and cites advantages of its increasingly integrated offering, the analyst tells investors in a research note.
Barclays
Overweight
downgrade
$522 -> $480
2025-06-02
Reason
Barclays
Price Target
$522 -> $480
2025-06-02
downgrade
Overweight
Reason
Barclays lowered the firm's price target on Elevance Health to $480 from $522 and keeps an Overweight rating on the shares. Following Q1 earnings and "several negative data points" around Part D mix, Affordable Care Act trend, and preliminary 2026 ACA rates, the firm is more concerned on the Medicare Part D and individual ACA businesses, which it believes carry negative earnings risk for the balance of 2025 and face significant premium increases and disruption in 2026. With limited prospects of multiple expansion and an unfavorable managed care catalyst calendar, investors are likely to be more sensitive to earnings revisions, which skew negatively for Part D- and ACA-sensitive stocks, the analyst tells investors in a research note. Barclays continues to prefer hospitals to managed care.
Argus
Buy
maintain
$450 -> $465
2025-04-25
Reason
Argus
Price Target
$450 -> $465
2025-04-25
maintain
Buy
Reason
Argus raised the firm's price target on Elevance Health to $465 from $450 and keeps a Buy rating on the shares. The company's results calmed concerns raised by a competitor in the managed-care space about pressure from rising medical costs in the Medicare Advantage business, and Elevance remains on the path to achieve margin recovery for its commercial business, the analyst tells investors in a research note.
RBC Capital
Ben Hendrix
Buy
Reiterates
$478
2025-04-23
Reason
RBC Capital
Ben Hendrix
Price Target
$478
2025-04-23
Reiterates
Buy
Reason
Guggenheim
Jason Cassorla
Strong Buy
Reiterates
$518
2025-04-23
Reason
Guggenheim
Jason Cassorla
Price Target
$518
2025-04-23
Reiterates
Strong Buy
Reason
Cantor Fitzgerald
Sarah James
Buy
Reiterates
$485
2025-04-23
Reason
Cantor Fitzgerald
Sarah James
Price Target
$485
2025-04-23
Reiterates
Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Elevance Health Inc (ELV.N) is 10.89, compared to its 5-year average forward P/E of 13.96. For a more detailed relative valuation and DCF analysis to assess Elevance Health Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average PE
13.96
Current PE
10.89
Overvalued PE
15.48
Undervalued PE
12.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average EV/EBITDA
10.45
Current EV/EBITDA
8.45
Overvalued EV/EBITDA
11.34
Undervalued EV/EBITDA
9.55

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average PS
0.64
Current PS
0.44
Overvalued PS
0.72
Undervalued PS
0.56

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 135.25% over the last quarter.
Sold
Bought
Congress Trading
Congress areSelling! The selling amount has increased912.5%over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

ELV News & Events

Events Timeline

(ET)
2025-06-16
16:31:35
Senate Republicans abandon Medicare cost cuts, Bloomberg reports
select
2025-06-05 (ET)
2025-06-05
14:06:21
Senate Republicans consider Medicare spending cuts, Bloomberg says
select
2025-06-04 (ET)
2025-06-04
06:10:27
Trump conceals Medicaid cuts in effort to pass major tax bill, Bloomberg says
select
link
Sign Up For More Events
Sign Up For More Events

News

Preview
3.0
06-19NASDAQ.COM
ELV Factor-Based Stock Analysis

  • ELEVANCE HEALTH INC Analysis: ELEVANCE HEALTH INC (ELV) has received a high rating of 79% from Validea's Low PE Investor model, indicating strong interest based on its earnings growth and valuation in the insurance industry.

  • John Neff's Investment Strategy: John Neff, known for his conservative investment approach, achieved impressive returns with the Windsor Fund, significantly outperforming the S&P 500 over three decades, demonstrating the effectiveness of his investment strategies.

Preview
4.0
06-18TipRanks
Top Analysts Pound the Table on These Three Stocks, 6/18/2025

  • Top Stock Picks: Analysts have identified three stocks as Strong Buys: Strategy (MSTR) with a 55.54% upside, Disc Medicine (IRON) with a 103.8% upside, and Elevance Health (ELV) with a 30% upside, all receiving recent Buy ratings from top analysts.

  • Analyst Rankings: TipRanks provides a tool to track real-time stock ratings from top-ranking financial analysts, highlighting their success rates and average returns on recommendations.

Preview
7.0
06-18Globenewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV

  • Class Action Lawsuit Filed: A class action lawsuit has been initiated against Elevance Health, Inc. for alleged securities fraud and unlawful business practices, with investors encouraged to contact Pomerantz LLP for participation by July 11, 2025.

  • Stock Price Decline: Following disappointing financial results and increased Medicaid costs disclosed during earnings calls in July and October 2024, Elevance's stock price experienced significant declines of 5.8% and 10.6%, respectively.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Elevance Health Inc (ELV) stock price today?

The current price of ELV is 375.91 USD — it has increased 0.19 % in the last trading day.

arrow icon

What is Elevance Health Inc (ELV)'s business?

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

arrow icon

What is the price predicton of ELV Stock?

Wall Street analysts forecast ELV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELV is 494.20 USD with a low forecast of 428.00 USD and a high forecast of 585.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Elevance Health Inc (ELV)'s revenue for the last quarter?

Elevance Health Inc revenue for the last quarter amounts to 48.89B USD, increased 14.83 % YoY.

arrow icon

What is Elevance Health Inc (ELV)'s earnings per share (EPS) for the last quarter?

Elevance Health Inc. EPS for the last quarter amounts to 9.61 USD, increased 0.21 % YoY.

arrow icon

What changes have occurred in the market's expectations for Elevance Health Inc (ELV)'s fundamentals?

The market is revising Upward the revenue expectations for Elevance Health, Inc. (ELV) for FY2025, with the revenue forecasts being adjusted by 1.22% over the past three months. During the same period, the stock price has changed by -12.68%.
arrow icon

How many employees does Elevance Health Inc (ELV). have?

Elevance Health Inc (ELV) has 103158 emplpoyees as of June 20 2025.

arrow icon

What is Elevance Health Inc (ELV) market cap?

Today ELV has the market capitalization of 84.93B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free